Feedback Regulation between Zipcode Binding Protein 1 and β-Catenin mRNAs in Breast Cancer Cells

REFERENCES

• Capodieci, P., M. Donovan, H. Buchinsky, Y. Jeffers, C. Cordon-Cardo, W. Gerald, J. Edelson, S. M. Shenoy, and R. H. Singer. 2005. Gene expression profiling in single cells within tissue. Nat. Methods 2:663–665.
   PubMedGoogle Scholar
• Castrop, J., K. van Norren, and H. Clevers. 1992. A gene family of HMG-box transcription factors with homology to TCF-1. Nucleic Acids Res. 20:611.
   PubMedGoogle Scholar
• Condeelis, J., and R. H. Singer. 2005. How and why does beta-actin mRNA target? Biol. Cell 97:97–110.
   PubMedGoogle Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Doyle, G. A., N. A. Betz, P. F. Leeds, A. J. Fleisig, R. D. Prokipcak, and J. Ross. 1998. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins. Nucleic Acids Res. 26:5036–5044.
   PubMed Web of Science ®Google Scholar
• Elbashir, S. M., J. Harborth, K. Weber, and T. Tuschl. 2002. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26:199–213.
   PubMed Web of Science ®Google Scholar
• Elbashir, S. M., W. Lendeckel, and T. Tuschl. 2001. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15:188–200.
   PubMed Web of Science ®Google Scholar
• Gavert, N., M. Conacci-Sorrell, D. Gast, A. Schneider, P. Altevogt, T. Brabletz, and A. Ben-Ze'ev. 2005. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J. Cell Biol. 168:633–642.
   PubMed Web of Science ®Google Scholar
• Gilles, C., M. Polette, M. Mestdagt, B. Nawrocki-Raby, P. Ruggeri, P. Birembaut, and J. M. Foidart. 2003. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 63:2658–2664.
   PubMed Web of Science ®Google Scholar
• Gu, L., K. Shigemasa, and K. Ohama. 2004. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer. Int. J. Oncol. 24:671–678.
   PubMed Web of Science ®Google Scholar
• Gu, W., C. Morales, and N. B. Hecht. 1995. In male mouse germ cells, copper-zinc superoxide dismutase utilizes alternative promoters that produce multiple transcripts with different translation potential. J. Biol. Chem. 270:236–243.
   PubMedGoogle Scholar
• Hansen, T. V. O., N. A. Hammer, J. Nielsen, M. Madsen, C. Dalbaeck, U. M. Wewer, J. Christiansen, and F. C. Nielsen. 2004. Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol. Cell. Biol. 24:4448–4464.
   PubMed Web of Science ®Google Scholar
• Hatsell, S., T. Rowlands, M. Hiremath, and P. Cowin. 2003. Beta-catenin and Tcfs in mammary development and cancer. J. Mammary Gland Biol. Neoplasia 8:145–158.
   PubMed Web of Science ®Google Scholar
• Hovanes, K., T. W. Li, and M. L. Waterman. 2000. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res. 28:1994–2003.
   PubMed Web of Science ®Google Scholar
• Howe, L. R., O. Watanabe, J. Leonard, and A. M. Brown. 2003. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res. 63:1906–1913.
   PubMed Web of Science ®Google Scholar
• Huttelmaier, S., D. Zenklusen, M. Lederer, J. Dictenberg, M. Lorenz, X. Meng, G. J. Bassell, J. Condeelis, and R. H. Singer. 2005. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature 438:512–515.
   PubMed Web of Science ®Google Scholar
• Ioannidis, P., L. Mahaira, A. Papadopoulou, M. R. Teixeira, S. Heim, J. A. Andersen, E. Evangelou, U. Dafni, N. Pandis, and T. Trangas. 2003. 8q24 copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas. Int. J. Cancer 104:54–59.
   PubMed Web of Science ®Google Scholar
• Ioannidis, P., L. Mahaira, A. Papadopoulou, M. R. Teixeira, S. Heim, J. A. Andersen, E. Evangelou, U. Dafni, N. Pandis, and T. Trangas. 2003. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression. Anticancer Res. 23:2179–2183.
   PubMedGoogle Scholar
• Ioannidis, P., L. G. Mahaira, S. A. Perez, A. D. Gritzapis, P. A. Sotiropoulou, G. J. Kavalakis, A. I. Antsaklis, C. N. Baxevanis, and M. Papamichail. 2005. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells. J. Biol. Chem. 280:20086–20093.
   PubMed Web of Science ®Google Scholar
• Ioannidis, P., T. Trangas, E. Dimitriadis, M. Samiotaki, I. Kyriazoglou, C. M. Tsiapalis, C. Kittas, N. Agnantis, F. C. Nielsen, J. Nielsen, J. Christiansen, and N. Pandis. 2001. C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors. Int. J. Cancer 94:480–484.
   PubMed Web of Science ®Google Scholar
• Kislauskis, E. H., X. Zhu, and R. H. Singer. 1997. β-Actin messenger RNA localization and protein synthesis augment cell motility. J. Cell Biol. 136:1263–1270.
   PubMedGoogle Scholar
• Kobel, M., D. Weidensdorfer, C. Reinke, M. Lederer, W. D. Schmitt, K. Zeng, C. Thomssen, S. Hauptmann, and S. Huttelmaier. 2007. Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma. Oncogene 26:7584–7589.
   PubMed Web of Science ®Google Scholar
• Korinek, V., N. Barker, P. J. Morin, D. van Wichen, R. de Weger, K. W. Kinzler, B. Vogelstein, and H. Clevers. 1997. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC−/− colon carcinoma. Science 275:1784–1787.
   PubMed Web of Science ®Google Scholar
• Lapidus, K., J. Wyckoff, G. Mouneimne, M. Lorenz, L. Soon, J. S. Condeelis, and R. H. Singer. 2007. ZBP1 enhances cell polarity and reduces chemotaxis. J. Cell Sci. 120:3173–3178.
   PubMedGoogle Scholar
• Leeds, P., B. T. Kren, J. M. Boylan, N. A. Betz, C. J. Steer, P. A. Gruppuso, and J. Ross. 1997. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro. Oncogene 14:1279–1286.
   PubMedGoogle Scholar
• Liao, B., M. Patel, Y. Hu, S. Charles, D. J. Herrick, and G. Brewer. 2004. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells. J. Biol. Chem. 279:48716–48724.
   PubMedGoogle Scholar
• Lin, S. Y., W. Xia, J. C. Wang, K. Y. Kwong, B. Spohn, Y. Wen, R. G. Pestell, and M. C. Hung. 2000. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. USA 97:4262–4266.
   PubMed Web of Science ®Google Scholar
• Logan, C. Y., and R. Nusse. 2004. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20:781–810.
   PubMed Web of Science ®Google Scholar
• Nielsen, F. C., J. Nielsen, and J. Christiansen. 2001. A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand. J. Clin. Lab. Invest. Suppl. 234:93–99.
   PubMedGoogle Scholar
• Nielsen, J., J. Christiansen, J. Lykke-Andersen, A. H. Johnsen, U. M. Wewer, and F. C. Nielsen. 1999. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol. Cell. Biol. 19:1262–1270.
   PubMed Web of Science ®Google Scholar
• Noubissi, F. K., I. Elcheva, N. Bhatia, A. Shakoori, A. Ougolkov, J. Liu, T. Minamoto, J. Ross, S. Y. Fuchs, and V. S. Spiegelman. 2006. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature 441:898–901.
   PubMed Web of Science ®Google Scholar
• Oleynikov, Y. 1999. Ph.D. thesis. Albert Einstein College of Medicine, Bronx, NY.
   Google Scholar
• Oleynikov, Y., and R. H. Singer. 2003. Real-time visualization of ZBP1 association with beta-actin mRNA during transcription and localization. Curr. Biol. 13:199–207.
   PubMed Web of Science ®Google Scholar
• Pan, F., S. Hüttelmaier, R. H. Singer, and W. Gu. 2007. ZBP2 facilitates binding of ZBP1 to β-actin mRNA during transcription. Mol. Cell. Biol. 27:8340–8351.
   PubMed Web of Science ®Google Scholar
• Ross, A. F., Y. Oleynikov, E. H. Kislauskis, K. L. Taneja, and R. H. Singer. 1997. Characterization of a β-actin mRNA zipcode-binding protein. Mol. Cell. Biol. 17:2158–2165.
   PubMed Web of Science ®Google Scholar
• Ross, J., I. Lemm, and B. Berberet. 2001. Overexpression of an mRNA-binding protein in human colorectal cancer. Oncogene 20:6544–6550.
   PubMedGoogle Scholar
• Rubinfeld, B., I. Albert, E. Porfiri, C. Fiol, S. Munemitsu, and P. Polakis. 1996. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023–1026.
   PubMed Web of Science ®Google Scholar
• Runge, S., F. C. Nielsen, J. Nielsen, J. Lykke-Andersen, U. M. Wewer, and J. Christiansen. 2000. H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. J. Biol. Chem. 275:29562–29569.
   PubMed Web of Science ®Google Scholar
• Sawadogo, M., and R. G. Roeder. 1985. Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay. Proc. Natl. Acad. Sci. USA 82:4394–4398.
   PubMed Web of Science ®Google Scholar
• Sinn, E., W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder. 1987. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49:465–475.
   PubMed Web of Science ®Google Scholar
• Stadeli, R., R. Hoffmans, and K. Basler. 2006. Transcription under the control of nuclear Arm/beta-catenin. Curr. Biol. 16:R378–R385.
   PubMed Web of Science ®Google Scholar
• Tessier, C. R., G. A. Doyle, B. A. Clark, H. C. Pitot, and J. Ross. 2004. Mammary tumor induction in transgenic mice expressing an RNA-binding protein. Cancer Res. 64:209–214.
   PubMed Web of Science ®Google Scholar
• Travis, A., A. Amsterdam, C. Belanger, and R. Grosschedl. 1991. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function. Genes Dev. 5:880–894.
   PubMed Web of Science ®Google Scholar
• van de Wetering, M., M. Oosterwegel, D. Dooijes, and H. Clevers. 1991. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J. 10:123–132.
   PubMed Web of Science ®Google Scholar
• Vikesaa, J., T. V. Hansen, L. Jonson, R. Borup, U. M. Wewer, J. Christiansen, and F. C. Nielsen. 2006. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J. 25:1456–1468.
   PubMed Web of Science ®Google Scholar
• Wang, W., S. Goswami, K. Lapidus, A. L. Wells, J. B. Wyckoff, E. Sahai, R. H. Singer, J. E. Segall, and J. S. Condeelis. 2004. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res. 64:8585–8594.
   PubMed Web of Science ®Google Scholar
• Wang, W., J. B. Wyckoff, V. C. Frohlich, Y. Oleynikov, S. Huttelmaier, J. Zavadil, L. Cermak, E. P. Bottinger, R. H. Singer, J. G. White, J. E. Segall, and J. S. Condeelis. 2002. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res. 62:6278–6288.
   PubMed Web of Science ®Google Scholar
• Yaniv, K., and J. K. Yisraeli. 2002. The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis. Gene 287:49–54.
   PubMed Web of Science ®Google Scholar
• Yisraeli, J. K. 2005. VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. Biol. Cell 97:87–96.
   PubMed Web of Science ®Google Scholar
• Yiu, G. K., M. T. Murray, and N. B. Hecht. 1997. Deoxyribonucleic acid-protein interactions associated with transcriptional initiation of the mouse testis-specific cytochrome c gene. Biol. Reprod. 56:1439–1449.
   PubMedGoogle Scholar